Testing effectiveness (Phase 2)Study completedNCT00123591
What this trial is testing
Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury
Who this might be right for
Acquired Bleeding DisorderTrauma
Novo Nordisk A/S 96